Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
64.00
-0.60 (-0.93%)
At close: Sep 24, 2026
| Market Cap | 6.87B +12.7% |
| Revenue (ttm) | 10.57B +24.8% |
| Net Income | 606.13M +35.3% |
| EPS | 5.60 +34.4% |
| Shares Out | 107.42M |
| PE Ratio | 11.42 |
| Forward PE | n/a |
| Dividend | 1.40 (2.19%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 609,589 |
| Open | 65.00 |
| Previous Close | 64.60 |
| Day's Range | 63.80 - 65.90 |
| 52-Week Range | 45.50 - 78.00 |
| Beta | 0.18 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 28, 2026 |